BJA Advance Access published online on March 4, 2005
British Journal of Anaesthesia, doi:10.1093/bja/aei105
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 OUTCOMES RESEARCHTM Institute, University of Louisville, Louisville, KY, USA; Department of Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, KY, USA
* To whom correspondence should be addressed. Background. Hypothermia may be an effective treatment for stroke or acute myocardial infarction; however, it provokes vigorous shivering, which causes potentially dangerous haemodynamic responses and prevents further hypothermia. Magnesium is an attractive anti-shivering agent because it is used for treatment of postoperative shivering and provides protection against ischaemic injury in animal models. We tested the hypothesis that magnesium reduces the threshold (triggering core temperature) and gain of shivering without substantial sedation or muscle weakness. Methods. We studied nine healthy male volunteers (18-40 yr) on two randomly assigned treatment days: (1) control and (2) magnesium (80 mg kg-1 followed by infusion at 2 g h-1). Lactated Ringer's solution (4°C) was infused via a central venous catheter over a period of approximately 2 h to decrease tympanic membrane temperature by Results. Magnesium reduced the shivering threshold (36.3 [SD 0.4] °C vs 36.6 [0.3] °C, P = 0.040). It did not affect the gain of shivering (control, 437 [289] ml min-1 °C-1; magnesium, 573 [370] ml min-1 °C-1; P=0.344). The magnesium bolus did not produce significant sedation or appreciably reduce muscle strength. Conclusions. Magnesium significantly reduced the shivering threshold. However, in view of the modest absolute reduction, this finding is considered to be clinically unimportant for induction of therapeutic hypothermia.
Accepted January 21, 2005
Clinical Investigation
Magnesium sulphate only slightly reduces the shivering threshold in humans
2 OUTCOMES RESEARCHTM Institute, University of Louisville, Louisville, KY, USA
3 Department of Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, KY, USA
A. G. Doufas, E-mail: agdoufas{at}louisville.edu
Abstract 
1.5°C h-1. A significant and persistent increase in oxygen consumption identified the threshold. The gain of shivering was determined by the slope of oxygen consumption vs core temperature regression. Sedation was evaluated using a verbal rating score (VRS) from 0 to 10 and bispectral index (BIS) of the EEG. Peripheral muscle strength was evaluated using dynamometry and spirometry. Data were analysed using repeated measures ANOVA; P<0.05 was statistically significant.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. I. Sessler Defeating Normal Thermoregulatory Defenses: Induction of Therapeutic Hypothermia Stroke, November 1, 2009; 40(11): e614 - e621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Meloni, K. Campbell, H. Zhu, and N. W. Knuckey In Search of Clinical Neuroprotection After Brain Ischemia: The Case for Mild Hypothermia (35{degrees}C) and Magnesium Stroke, June 1, 2009; 40(6): 2236 - 2240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Horn, C. Thompson, D. Woods, A. Nel, A. Bekker, N. Rhoda, and C. Pieper Induced Hypothermia for Infants With Hypoxic- Ischemic Encephalopathy Using a Servo-Controlled Fan: An Exploratory Pilot Study Pediatrics, June 1, 2009; 123(6): e1090 - e1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Neumar, J. P. Nolan, C. Adrie, M. Aibiki, R. A. Berg, B. W. Bottiger, C. Callaway, R. S.B. Clark, R. G. Geocadin, E. C. Jauch, et al. Post-Cardiac Arrest Syndrome: Epidemiology, Pathophysiology, Treatment, and Prognostication A Consensus Statement From the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council Circulation, December 2, 2008; 118(23): 2452 - 2483. [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Ryu, M.-H. Kang, K.-S. Park, and S.-H. Do Effects of magnesium sulphate on intraoperative anaesthetic requirements and postoperative analgesia in gynaecology patients receiving total intravenous anaesthesia Br. J. Anaesth., March 1, 2008; 100(3): 397 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lysakowski, L. Dumont, C. Czarnetzki, and M. R. Tramer Magnesium as an Adjuvant to Postoperative Analgesia: A Systematic Review of Randomized Trials Anesth. Analg., June 1, 2007; 104(6): 1532 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Hemmen and P. D. Lyden Induced Hypothermia for Acute Stroke Stroke, February 1, 2007; 38(2): 794 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Thanthulage, S. G. Stacey, and A. G. Doufas Magnesium sulphate and ischaemic heart disease Br. J. Anaesth., March 1, 2006; 96(3): 403 - 404. [Full Text] [PDF]
|
|